Skip to content

AngioDynamics ANGO Finance Lease, Principal Payments

Finance Lease, Principal Payments at other companies

Boston Scientific logo
Boston ScientificBSX
$0-100%
ICU Medical logo
ICU MedicalICUI
Penumbra logo
PenumbraPEN
ITG
Integer HoldingsITGR
Nordson logo
NordsonNDSN

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0.0×
Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's finance lease, principal payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's finance lease, principal payments?
AngioDynamics (ANGO) reported finance lease, principal payments of $95K in Q4 2025.
How has AngioDynamics's finance lease, principal payments changed year-over-year?
AngioDynamics's finance lease, principal payments increased by 63.8% year-over-year, from $58K to $95K.